Chicago Partners Investment Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Chicago Partners Investment Group's IBB Position: Q2 2026 in Review
Chicago Partners Investment Group increased its iShares Biotechnology ETF (IBB) stake by 0.76% in Q2 2026, buying an estimated $10.3K and bringing the position to 7,922 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #476.
Chicago Partners Investment Group first reported a position in IBB in Q3 2018 and has held it in 18 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Chicago Partners Investment Group held 7,922 shares of iShares Biotechnology ETF worth $1.5M as of Q2 2026.
- Chicago Partners Investment Group bought 60 iShares Biotechnology ETF shares in Q2 2026, an estimated $10.3K.
- iShares Biotechnology ETF made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #476 holding.
- Chicago Partners Investment Group first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 18 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.